MedTrace Logo

An Evaluation of Patient Reported Outcomes and Clinical Outcomes

NCT06092970 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 379

Last updated 2025-08-01

No results posted yet for this study

Summary

This extension study is being conducted to assess the following objectives through 12 months post-cardiac surgery:

* Patient reported outcomes (PRO), using the EQ-5D questionnaire
* Clinical outcomes

Conditions

  • Post-Operative Complications in Cardiac Surgery

Interventions

DRUG

RBT-1

Intravenous administration

DRUG

Placebo

Intravenous administration

Sponsors & Collaborators

  • Renibus Therapeutics, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-16
Primary Completion
2026-06-30
Completion
2026-06-30
FDA Drug
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06092970 on ClinicalTrials.gov